Braintree Laboratories, a part of Sebela Pharmaceuticals® and a leading manufacturer of gastroenterology pharmaceutical products, today announced positive topline results from two pivotal US Phase 3 ...

Chronic cutaneous immune-related adverse events often persist more than a year after discontinuation of immune checkpoint inhibitor therapy. The findings highlight the importance of dermatology ...

A doctor from Shanghai Ruijin Hospital discusses the latest clinical use of China's first domestically produced proton therapy system during a media briefing on April 15, 2025. [Photo by Li ...

Proton therapy is a type of radiation therapy, and experts say that global studies suggest that it may cause fewer side effects than traditional radiation. The central institute is in talks with ...

Proton pump inhibitor therapy is well tolerated at standard doses; even a fivefold increase in the AUC of PPIs appears to cause only negligible side effects. The clinical relevance of these ...

We have outlined several mechanisms by which cancer cells develop resistance to radiation therapy. We have also provided mechanistic ... that protect the use of proton pump inhibitors (PPIs) for ...

Background and Objectives: Although the relationship between the use of proton pump inhibitors (PPIs ... some patients may still be infected with pulmonary TB even after PPI therapy. On the other ...